Literature DB >> 9186134

Famciclovir for the treatment of acute retinal necrosis (ARN) syndrome.

M S Figueroa1, I Garabito, C Gutierrez, J Fortun.   

Abstract

PURPOSE: To document a case of acute retinal necrosis syndrome in an immunocompetent patient who was successfully treated with famciclovir after unsuccessful treatment with acyclovir.
METHODS: After diagnosing acute retinal necrosis syndrome in the patient's left eye, we treated him with 13 mg/kg/24 hours of intravenous acyclovir in three daily doses for 14 days, followed by 800 mg of acyclovir five times per day orally. New areas of retinitis developed within the posterior pole despite treatment with the maximum dosage of acyclovir; thus, we used a new antiviral agent, famciclovir.
RESULTS: When we administered 500 mg of famciclovir orally every 8 hours for 3 months, the retinitis regressed within 1 month, leaving atrophic granular pigmented scars.
CONCLUSION: Famciclovir can effectively treat acute retinal necrosis syndrome in immunocompetent patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186134     DOI: 10.1016/s0002-9394(14)71045-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

Review 1.  Advances in the management of acute retinal necrosis.

Authors:  Jessica G Shantha; Heather M Weissman; Matthew R Debiec; Thomas A Albini; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2015

Review 2.  Viral posterior uveitis.

Authors:  Joanne H Lee; Aniruddha Agarwal; Padmamalini Mahendradas; Cecilia S Lee; Vishali Gupta; Carlos E Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 3.  Antimicrobial guide to posterior segment infections.

Authors:  Tapan P Patel; David N Zacks; Vaidehi S Dedania
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-06       Impact factor: 3.117

4.  [Acute retinal necrosis from the virologist's perspective].

Authors:  P Rautenberg; L Grancicova; J Hillenkamp; B Nölle; J B Roider; H Fickenscher
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

5.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02

6.  Time profile of viral DNA in aqueous humor samples of patients treated for varicella-zoster virus acute retinal necrosis by use of quantitative real-time PCR.

Authors:  D Bernheim; R Germi; M Labetoulle; J P Romanet; P Morand; C Chiquet
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

Review 7.  Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.

Authors:  R Snoeck; G Andrei; E De Clercq
Journal:  Drugs       Date:  1999-02       Impact factor: 11.431

8.  Clinical manifestation of self-limiting acute retinal necrosis.

Authors:  Joanna Brydak-Godowska; Piotr Borkowski; Szymon Szczepanik; Joanna Moneta-Wielgoś; Dariusz Kęcik
Journal:  Med Sci Monit       Date:  2014-10-30

9.  Valacyclovir in the treatment of acute retinal necrosis.

Authors:  Simon Rj Taylor; Robin Hamilton; Claire Y Hooper; Lavnish Joshi; Jiten Morarji; Nitin Gupta; Sue L Lightman
Journal:  BMC Ophthalmol       Date:  2012-09-05       Impact factor: 2.209

10.  Acute multifocal hemorrhagic retinal vasculitis in a child: a case report.

Authors:  Malik Y Ghannam; Mohammed Naseemuddin; Peter Weiser; John O Mason
Journal:  BMC Ophthalmol       Date:  2016-10-18       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.